CoChat

Omega-3 polyunsaturated fatty acids for cardiovascular diseases: present, past and future

Watanabe, Yasuhiro, Tatsuno, Ichiro · 2017 · Expert Review of Clinical Pharmacology
Cited by 93

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Abstract

INTRODUCTION: Large-scale epidemiological studies on Greenlandic, Canadian and Alaskan Eskimos have examined the health benefits of omega-3 fatty acids consumed as part of the diet, and found statistically significant relative reduction in cardiovascular risk in people consuming omega-3 fatty acids. Areas covered: This article reviews studies on omega-3 fatty acids during the last 50 years, and identifies issues relevant to future studies on cardiovascular (CV) risk. Expert commentary: Although a meta-analysis of large-scale prospective cohort studies and randomized studies reported that fish and fish oil consumption reduced coronary heart disease-related mortality and sudden cardiac death, omega-3 fatty acids have not yet been shown to be effective in secondary prevention trials on patients with multiple cardiovascular disease (CVD) risk factors. The ongoing long-term CV interventional outcome studies investigate high-dose, prescription-strength omega-3 fatty acids. The results are expected to clarify the potential role of omega-3 fatty acids in reducing CV risk. The anti-inflammatory properties of omega-3 fatty acids are also important. Future clinical trials should also focus on the role of these anti-inflammatory mediators in human arteriosclerotic diseases as well as inflammatory diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/17512433.2017.1333902

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 40 references

Research works printed but not linked: 62

  1. 10.1001/jama.2009.1178 · DOI · Paper page
  2. Kimura N, 1970, Circulation, 41, I101
  3. Bang HO, 1976, Acta Med Scand, 200, 69, 10.1111/j.0954-6820.1976.tb08198.x · DOI · Paper page
  4. Sinclair HM, 1952, Br J Nutr, 12, 69
  5. Parkinson AJ, 1994, Am J Clin Nutr, 59, 384, 10.1093/ajcn/59.2.384 · DOI
  6. 10.1016/0021-9150(83)90181-8 · DOI · Paper page
  7. 10.1016/j.jacl.2013.09.002 · DOI
  8. 10.2459/01.JCM.0000289269.98105.65 · DOI
  9. Nordoy A, 1991, Am J Clin Nutr, 53, 1185, 10.1093/ajcn/53.5.1185 · DOI
  10. 10.1016/S0002-9149(96)00159-2 · DOI · Paper page
  11. 10.2146/ajhp060164 · DOI · Paper page
  12. 10.1586/14779072.6.3.391 · DOI · Paper page
  13. 10.1016/j.jacl.2014.02.036 · DOI
  14. 10.1111/1755-5922.12146 · DOI
  15. 10.1016/j.amjcard.2005.12.026 · DOI · Paper page
  16. 10.1016/j.atherosclerosis.2012.01.006 · DOI · Paper page
  17. 10.1016/j.atherosclerosis.2013.10.014 · DOI · Paper page
  18. 10.1016/j.jnutbio.2014.02.004 · DOI
  19. 10.1016/j.numecd.2016.07.012 · DOI
  20. 10.1016/j.prostaglandins.2015.05.003 · DOI
  21. 10.1007/s11745-001-0692-x · DOI · Paper page
  22. 10.1016/j.jjcc.2014.01.005 · DOI
  23. 10.1172/JCI110288 · DOI · Paper page
  24. Chang KJ, 1991, J Leukoc Biol, 50, 273, 10.1002/jlb.50.3.273 · DOI
  25. 10.1007/BF01966464 · DOI
  26. 10.1016/j.atherosclerosis.2008.07.045 · DOI
  27. 10.1016/j.atherosclerosis.2007.07.023 · DOI
  28. 10.4049/jimmunol.0903282 · DOI
  29. 10.1053/ajkd.2001.27392 · DOI · Paper page
  30. 10.1056/NEJM197403282901301 · DOI · Paper page
  31. 10.4103/2279-042X.192451 · DOI
  32. 10.1001/2012.jama.11374 · DOI · Paper page
  33. 10.1016/j.atherosclerosis.2013.11.073 · DOI
  34. 10.1161/JAHA.113.000506 · DOI · Paper page
  35. 10.1016/j.amepre.2016.07.020 · DOI
  36. Gobbo LCD, 2016, JAMA Intern Med, 94305, 1
  37. 10.1161/01.CIR.0000055315.79177.16 · DOI · Paper page
  38. 10.1016/j.mayocp.2016.10.018 · DOI · Paper page
  39. 10.1016/j.mayocp.2016.11.008 · DOI
  40. 10.1016/S0140-6736(07)60527-3 · DOI · Paper page
  41. 10.1016/j.atherosclerosis.2013.11.048 · DOI
  42. 10.1177/2047487313517576 · DOI
  43. 10.1161/01.CIR.0000031732.78052.81 · DOI · Paper page
  44. 10.1016/j.atherosclerosis.2015.02.033 · DOI
  45. Malik AR, 2007, J Hum Hypertens, 21, 231, 10.1038/sj.jhh.1002143 · DOI
  46. 10.1681/ASN.2005121288 · DOI · Paper page
  47. 10.1186/1476-511X-9-7 · DOI
  48. 10.1016/j.jacc.2005.03.038 · DOI · Paper page
  49. 10.1161/CIRCHEARTFAILURE.110.960450 · DOI · Paper page
  50. 10.1093/eurjhf/hfq172 · DOI · Paper page
  51. 10.1161/CIR.0b013e31829e8807 · DOI · Paper page
  52. 10.1001/jama.295.22.2613 · DOI · Paper page
  53. 10.1161/JAHA.112.005033 · DOI · Paper page
  54. 10.1038/ejcn.2012.133 · DOI · Paper page
  55. 10.1161/CIRCULATIONAHA.115.019949 · DOI · Paper page
  56. 10.1152/ajpheart.01057.2009 · DOI · Paper page
  57. 10.1016/j.yjmcc.2015.04.003 · DOI · Paper page
  58. 10.1084/jem.20132011 · DOI · Paper page
  59. 10.5551/jat.ED063 · DOI
  60. 10.1016/j.atherosclerosis.2013.09.023 · DOI
  61. 10.1016/j.amjcard.2012.08.038 · DOI
  62. 10.1002/fsn3.121 · DOI · Paper page

Cited by

See all 93

Metadata

Authors
Watanabe, Y., & Tatsuno, I.
Venue
Expert Review of Clinical Pharmacology
Published
2017-05-29
Volume
10
Issue
8
Pages
865-873
ISSN
  • 1751-2433 (ISSN-L)
  • 1751-2441
OpenAlex
W2614919993
Cited by
93
References
40
FWCI
7.18
Type
journal article
Language
en
Open access
closed
Funders
  • Eli Lilly and Company (no number)
  • Mochida Pharmaceutical Company (no number)
  • Takeda Pharmaceutical Company (no number)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Omega-3 polyunsaturated fatty acids for cardiovascular diseases: present, past and future. https://app.cochat.ai/papers/10.1080/17512433.2017.1333902
The paper
Watanabe, Y., & Tatsuno, I. (2017). Omega-3 polyunsaturated fatty acids for cardiovascular diseases: present, past and future. Expert Review of Clinical Pharmacology. https://doi.org/10.1080/17512433.2017.1333902

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.